companies

MindMaze

🦄
Founded 2012
Employees 100+
Primary contact
Chemin de Roseneck 5
1006 Lausanne
Switzerland
+41215520801
Links
https://www.mindmaze.com/
Sections
Technologies
MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence - its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer's disease, and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA-cleared and CE-marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. The company has offices in Lausanne, Baltimore, London, Paris and Mumbai.
Select partners: American Hospital Association, McLaren Racing, Mount Sinai Health System, Surgicorp, Alkholi, Guttmann Barcelona, Swiss Rehabilitation, Andretti Autosport.
🦄
Founded 2012
Employees 100+
Primary contact
Chemin de Roseneck 5
1006 Lausanne
Switzerland
+41215520801
Links
https://www.mindmaze.com/
Sections
Technologies

Funding 💰

Total 🦄 $340.7M
Last round 🔗 $105M
Other
February 17, 2022.
Select investors Hinduja Group, Leonardo DiCaprio, Concord Health Partners, AlbaCore Capital, Foundation for Technological Innovation (FIT), Venture Kick, Hambro Perks

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Already in use: As of April 2022, Mindmaze's health solutions have been used by more than 10,000 patients across 75+ hospitals and clinics in 20+ countries.
  • Investors love it: The company is the first Swiss Unicorn!
  • Digital therapeutics: As of April 2022, the company had candidate DTx products for 8 major neurological diseases.
  • Media love: MindMaze has been featured in such media outlets as Wired, Fast Company, ABC News, CBS, Forbes, The Financial Times, Sky News, Reuters, The Guardian, etc.
  • Eyes on the U.S. market: In addition to bringing its technology to Europe, Mindmaze is also looking to expand to the U.S. market, which is what its $105M raise in February 2022 will go to. 🔗

Video ▶️

In the news 📰

MindMaze launches smart peripheral for hand dexterity assessment and training
February 16, 2023

Quotes 💬

“
MindMaze has developed the leading technology and approach to digital therapeutics for neuro-rehabilitation and restoration, providing clear benefits to patients, providers and payors. We believe this notable advancement in treatment and therapy will meaningfully improve brain health and recovery for a wide range of conditions. We are thrilled to partner with Tej and the MindMaze team to build on its impressive track record and to support clinical and commercial expansion in the US market.
— James Olsen, Founder & Managing Partner at Concord Health Partners 🔗
“
The AHA is excited to join initiatives to promote and advance the delivery of digital therapeutic solutions for neurological diseases in accessible settings, and MindMaze will enable our hospitals, health care systems and other providers of care to offer new, innovative solutions to help treat their patients.
— Doug Shaw, Senior Vice President, Business Development at the American Hospital Association 🔗
Last update: August 14, 2022